The Role of Artificial Intelligence in Diabetic Retinopathy Market

The diabetic retinopathy market has witnessed notable progress in therapeutic interventions. Anti-vascular endothelial growth factor (VEGF) agents have revolutionized the treatment landscape by inhibiting abnormal blood vessel growth and reducing retinal edema. These intravitreal injections have shown promising results in preventing vision loss and improving visual acuity in patients with diabetic retinopathy.

https://www.innovationmarketresearch.com/market-reports/diabetic-retinopathy-market-size